References
- Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):1–19. doi:https://doi.org/10.3322/caac.21492.
- Harbeck N, Penault-Llorca F, Cortes J, Gnant M, Houssami N, Poortmans P, Ruddy K, Tsang J, Cardoso F. Breast cancer. Nat Rev Dis Primers. 2019;5:66.
- Perou CMS, Elsen T, Rijn MB, Jeffreyl M, Rees SS, C. A. Pollack JR, Johnsen RDT, Akslen H, Fluge LA, Pergamenschikov Q, et al. Molecular portraits of human breast tumours. nature. 2000;406(6797):6. doi:https://doi.org/10.1038/35021093.
- Shiovitz S, Korde LA. Genetics of breast cancer: a topic in evolution. Annals of Oncology. 2015;26(7):1291–1299. doi:https://doi.org/10.1093/annonc/mdv022.
- Chen WY, Rosner B, Hankinson SE, Colditz GA, Willett WC. Moderate Alcohol Consumption During Adult Life, Drinking Patterns, and Breast Cancer Risk. Jama-J Am Med Assoc. 2011;306(17):1884–1890. doi:https://doi.org/10.1001/jama.2011.1590.
- Danaei G, Vander Hoorn S, Lopez AD, Murray CJL, Ezzati M, Collab CRA. Causes of cancer in the world: comparative risk assessment of nine behavioural and environmental risk factors. Lancet. 2005;366(9499):1784–1793. doi:https://doi.org/10.1016/S0140-6736(05)67725-2.
- Ruffell B, Au A, Rugo HS, Esserman LJ, Hwang ES, Coussens LM. Leukocyte composition of human breast cancer. P Natl Acad Sci USA. 2012;109(8):2796–2801. doi:https://doi.org/10.1073/pnas.1104303108.
- Soysal SD, Tzankov A, Muenst SE. Role of the Tumor Microenvironment in Breast Cancer. Pathobiology. 2015;82:142–152.
- Wei CJ, Xu X, Lo CW. Connexins and cell signaling in development and disease. Annu Rev Cell Dev Biol. 2004;20(1):811–838. doi:https://doi.org/10.1146/annurev.cellbio.19.111301.144309.
- Bonacquisti EE, Nguyen J. Connexin 43 (Cx43) in cancer: implications for therapeutic approaches via gap junctions. Cancer Letters. 2019;442:439–444. doi:https://doi.org/10.1016/j.canlet.2018.10.043.
- Laird DW, Fistouris P, Batist G, Alpert L, Huynh HT, Carystinos GD, Alaoui-Jamali MA. Deficiency of connexin43 gap junctions is an independent marker for breast tumors. Cancer Research. 1999;59:4104–4110.
- Kanczuga-Koda L, Sulkowski S, Lenczewski A, Koda M, Wincewicz A, Baltaziak M, Sulkowska M. Increased expression of connexins 26 and 43 in lymph node metastases of breast cancer. J Clin Pathol. 2006;59(4):429–433. doi:https://doi.org/10.1136/jcp.2005.029272.
- Wilgenbus KK, Kirkpatrick CJ, Knuechel R, Willecke K, Traub O. Expression of Cx26, Cx32 and Cx43 Gap Junction Proteins in Normal and Neoplastic Human Tissues. International Journal of Cancer. 1992;51(4):522–529. doi:https://doi.org/10.1002/ijc.2910510404.
- Aasen T, Leithe E, Graham SV, Kameritsch P, Mayan MD, Mesnil M, Pogoda K, Tabernero A. Connexins in cancer: bridging the gap to the clinic. Oncogene. 2019;38(23):4429–4451. doi:https://doi.org/10.1038/s41388-019-0741-6.
- Mese G, Richard G, White TW. Gap junctions: basic structure and function. J Invest Dermatol. 2007;127(11):2516–2524. doi:https://doi.org/10.1038/sj.jid.5700770.
- Aasen T, Mesnil M, Naus CC, Lampe PD, Laird DW. Gap junctions and cancer: communicating for 50 years (vol 16, pg 775, 2016). Nature Reviews Cancer. 2017;17(1):74. doi:https://doi.org/10.1038/nrc.2016.142.
- Sinha G, Ferrer AI, Moore CA, Naaldijk Y, Rameshwar P. Gap Junctions and Breast Cancer Dormancy. Trends in Cancer. 2020;6(4):348–357. doi:https://doi.org/10.1016/j.trecan.2020.01.013.
- Laird DW, Revel JP. Biochemical and Immunochemical Analysis of the Arrangement of Connexin43 in Rat-Heart Gap Junction Membranes. Journal of Cell Science. 1990;97(1):109–117. doi:https://doi.org/10.1242/jcs.97.1.109.
- Goodenough DA, Paul DL. Gap Junctions. Csh Perspect Biol. 2009;1:1.
- Buratto D, Donati V, Zonta F, Mammano F. Harnessing the therapeutic potential of antibodies targeting connexin hemichannels. Bba-Mol Basis Dis. 2021;1867(4):4. doi:https://doi.org/10.1016/j.bbadis.2020.166047.
- Laird DW, Lampe PD. Therapeutic strategies targeting connexins. Nat Rev Drug Discov. 2018;17:905–921.
- Solan JL, Lampe PD. Connexin43 phosphorylation: structural changes and biological effects. Biochemical Journal. 2009;419(2):261–272. doi:https://doi.org/10.1042/BJ20082319.
- Leithe E, Mesnil M, Aasen T. The connexin 43 C-terminus: a tail of many tales. Biochimica Et Biophysica Acta (Bba)-biomembranes. 2018;1860:48–64.
- Evans WH, De Vuyst E, Leybaert L. The gap junction cellular internet: connexin hemichannels enter the signalling limelight. Biochemical Journal. 2006;397(1):1–14. doi:https://doi.org/10.1042/BJ20060175.
- Sohl G, Willecke K. An update on connexin genes and their nomenclature in mouse and man. Cell Communication and Adhesion. 2003;10(4–6):173–180. doi:https://doi.org/10.1080/cac.10.4-6.173.180.
- Beyer EC, Paul DL, Goodenough DA. Connexin Family of Gap Junction Proteins. J Membrane Biol. 1990;116(3):187–194. doi:https://doi.org/10.1007/BF01868459.
- Kumar NM, Gilula NB. The gap junction communication channel. Cell. 1996;84(3):381–388. doi:https://doi.org/10.1016/S0092-8674(00)81282-9.
- Kumar NM. Molecular biology of the interactions between connexins. Novart Fdn Symp. 1999;219:6–21.
- Beyer EC, Paul DL, Goodenough DA. Connexin43 - a Protein from Rat-Heart Homologous to a Gap Junction Protein from Liver. Journal of Cell Biology. 1987;105(6):2621–2629. doi:https://doi.org/10.1083/jcb.105.6.2621.
- Goodenough DA, Paul DL. Beyond the gap: functions of unpaired connexon channels. Nat Rev Mol Cell Bio. 2003;4(4):285–294. doi:https://doi.org/10.1038/nrm1072.
- Spray DC, Ye ZC, Ransom BR. “Functional connexin hemichannels”: a critical appraisal. Glia. 2006;54(7):758–773. doi:https://doi.org/10.1002/glia.20429.
- Laird DW. Life cycle of connexins in health and disease. Biochemical Journal. 2006;394:527–543.
- White TW. Nonredundant gap junction functions. News Physiol Sci. 2003;18:95–99.
- Sun JJ, Ahmad S, Chen SP, Tang WX, Zhang YP, Chen P, Lin X. Cochlear gap junctions coassembled from Cx26 and 30 show faster intercellular Ca2+ signaling than homomeric counterparts. Am J Physiol-Cell Ph. 2005;288(3):C613–C623. doi:https://doi.org/10.1152/ajpcell.00341.2004.
- Jiang JX, Goodenough DA. Heteromeric connexons in lens gap junction channels. P Natl Acad Sci USA. 1996;93(3):1287–1291. doi:https://doi.org/10.1073/pnas.93.3.1287.
- Hopperstad MG, Srinivas M, Spray DC. Properties of gap junction channels formed by Cx46 alone and in combination with Cx50. Biophysical Journal. 2000;79(4):1954–1966. doi:https://doi.org/10.1016/S0006-3495(00)76444-7.
- Koval M. Pathways and control of connexin oligomerization. Trends Cell Biol. 2006;16(3):159–166. doi:https://doi.org/10.1016/j.tcb.2006.01.006.
- Koval M, Molina SA, Burt JM. Mix and match: investigating heteromeric and heterotypic gap junction channels in model systems and native tissues. Febs Letters. 2014;588(8):1193–1204. doi:https://doi.org/10.1016/j.febslet.2014.02.025.
- Karademir LB, Aoyama H, Yue B, Chen HH, Bai DL. Engineered Cx26 variants established functional heterotypic Cx26/Cx43 and Cx26/Cx40 gap junction channels. Biochemical Journal. 2016;473(10):1391–1403. doi:https://doi.org/10.1042/BCJ20160200.
- Niessen H, Harz H, Bedner P, Kramer K, Willecke K. Selective permeability of different connexin channels to the second messenger inositol 1,4,5-trisphosphate. Journal of Cell Science. 2000;113(8):1365–1372. doi:https://doi.org/10.1242/jcs.113.8.1365.
- Ayad WA, Locke D, Koreen IV, Harris AL. Heteromeric, but not homomeric, connexin channels are selectively permeable to inositol phosphates. Journal of Biological Chemistry. 2006;281(24):16727–16739. doi:https://doi.org/10.1074/jbc.M600136200.
- Talhouk RS, Elble RC, Bassam R, Daher M, Sfeir A, Mosleh LA, El-Khoury H, Hamoui S, Pauli BU, El-Sabban ME. Developmental expression patterns and regulation of connexins in the mouse mammary gland: expression of connexin30 in lactogenesis. Cell Tissue Res. 2005;319(1):49–59. doi:https://doi.org/10.1007/s00441-004-0915-5.
- Locke D, Jamieson S, Stein T, Liu J, Hodgins MB, Harris AL, Gusterson B. Nature of Cx30-containing channels in the adult mouse mammary gland. Cell Tissue Res. 2007;328(1):97–107. doi:https://doi.org/10.1007/s00441-006-0301-6.
- McLachlan E, Shao Q, Laird DW. Connexins and gap junctions in mammary gland development and breast cancer progression. J Membr Biol. 2007;218(1–3):107–121. doi:https://doi.org/10.1007/s00232-007-9052-x.
- Beyer EC, Gemel J, Martinez A, Berthoud VM, Valiunas V, Moreno AP, Brink PR. Heteromeric mixing of connexins: compatibility of partners and functional consequences. Cell Commun Adhes. 2001;8(4–6):199–204. doi:https://doi.org/10.3109/15419060109080723.
- Locke D, Stein T, Davies C, Morris J, Harris AL, Evans WH, Monaghan P, Gusterson B. Altered permeability and modulatory character of connexin channels during mammary gland development. Experimental Cell Research. 2004;298(2):643–660. doi:https://doi.org/10.1016/j.yexcr.2004.05.003.
- Trexler EB, Bennett MVL, Bargiello TA, Verselis VK. Voltage gating and permeation in a gap junction hemichannel. P Natl Acad Sci USA. 1996;93(12):5836–5841. doi:https://doi.org/10.1073/pnas.93.12.5836.
- Oh S, Bargiello TA. Voltage Regulation of Connexin Channel Conductance. Yonsei Med J. 2015;56(1):1–15. doi:https://doi.org/10.3349/ymj.2015.56.1.1.
- Banerjee D. Connexin’s connection in breast cancer growth and progression. International Journal of Cell Biology. 2016;2016:9025905. doi: https://doi.org/10.1155/2016/9025905.
- Peracchia C. Chemical gating of gap junction channels Roles of calcium, pH and, calmodulin. Bba-Biomembranes. 2004;1662(1–2):61–80. doi:https://doi.org/10.1016/j.bbamem.2003.10.020.
- Liu SG, Taffet S, Stoner L, Delmar M, Vallano ML, Jalife J, Structural A. Basis for the Unequal Sensitivity of the Major Cardiac and Liver Gap-Junctions to Intracellular Acidification - the Carboxyl Tail Length. Biophysical Journal. 1993;64(5):1422–1433. doi:https://doi.org/10.1016/S0006-3495(93)81508-X.
- Eckert R. pH gating of lens fibre connexins. Pflug Arch Eur J Phy. 2002;443(5–6):843–851. doi:https://doi.org/10.1007/s00424-001-0760-2.
- Palacios-Prado N, Sonntag S, Skeberdis VA, Willecke K, Bukauskas FF. Gating, permselectivity and pH-dependent modulation of channels formed by connexin57, a major connexin of horizontal cells in the mouse retina. J Physiol-London. 2009;587(13):3251–3269. doi:https://doi.org/10.1113/jphysiol.2009.171496.
- Pfahnl A, Dahl G. Gating of cx46 gap junction hemichannels by calcium and voltage. Pflug Arch Eur J Phy. 1999;437(3):345–353. doi:https://doi.org/10.1007/s004240050788.
- Aasen T, Johnstone S, Vidal-Brime L, Lynn KS, Koval M. Connexins: synthesis, Post-Translational Modifications, and Trafficking in Health and Disease. Int J Mol Sci. 2018;19(5):5. doi:https://doi.org/10.3390/ijms19051296.
- Johnstone SR, Billaud M, Lohman AW, Taddeo EP, Isakson BE. Posttranslational Modifications in Connexins and Pannexins. J Membrane Biol. 2012;245(5–6):319–332. doi:https://doi.org/10.1007/s00232-012-9453-3.
- Pogoda K, Kameritsch P, Retamal MA, Vega JL. Regulation of gap junction channels and hemichannels by phosphorylation and redox changes: a revision. Bmc Cell Biol. 2016;17(1):137–150. doi:https://doi.org/10.1186/s12860-016-0099-3.
- Lampe PD, Cooper CD, King TJ, Burt JM. Analysis of Connexin43 phosphorylated at S325, S328 and S330 in normoxic and ischemic heart. Journal of Cell Science. 2006;119(16):3435–3442. doi:https://doi.org/10.1242/jcs.03089.
- O’Quinn MP, Palatinus JA, Harris BS, Hewett KW, Gourdie RG, Peptide A. Mimetic of the Connexin43 Carboxyl Terminus Reduces Gap Junction Remodeling and Induced Arrhythmia Following Ventricular Injury. Circ Res. 2011;108(6):704–715. doi:https://doi.org/10.1161/CIRCRESAHA.110.235747.
- Johnson KE, Mitra S, Katoch P, Kelsey LS, Johnson KR, Mehta PP. Phosphorylation on Ser-279 and Ser-282 of connexin43 regulates endocytosis and gap junction assembly in pancreatic cancer cells. Molecular Biology of the Cell. 2013;24(6):715–733. doi:https://doi.org/10.1091/mbc.e12-07-0537.
- Van Rijen HV, van Veen TA, Hermans MM, Jongsma HJ. Human connexin40 gap junction channels are modulated by cAMP. Cardiovascular Research. 2000;45(4):941–951. doi:https://doi.org/10.1016/S0008-6363(99)00373-9.
- Wu JF, Ji J, Dong SY, Li BB, Yu ML, Wu DD, Tao L, Tong XH. Gefitinib enhances oxaliplatin-induced apoptosis mediated by Src and PKC-modulated gap junction function. Oncology Reports. 2016;36(6):3251–3258. doi:https://doi.org/10.3892/or.2016.5156.
- John S, Cesario D, Weiss JN. Gap junctional hemichannels in the heart. Acta Physiol Scand. 2003;179(1):23–31. doi:https://doi.org/10.1046/j.1365-201X.2003.01197.x.
- Jedamzik B, Marten I, Ngezahayo A, Ernst A, Kolb HA. Regulation of lens rCx46-formed hemichannels by activation of protein kinase C, external Ca2+ and protons. J Membrane Biol. 2000;173(1):39–46. doi:https://doi.org/10.1007/s002320001005.
- Retamal MA, Cortes CJ, Reuss L, Bennett MVL, Saez JC. S-nitrosylation and permeation through connexin 43 hemichannels in astrocytes: induction by oxidant stress and reversal by reducing agents. P Natl Acad Sci USA. 2006;103(12):4475–4480. doi:https://doi.org/10.1073/pnas.0511118103.
- Shen YM, Li YX, Ma XF, Wan QH, Jiang ZM, Liu YX, Zhang DY, Liu XZ, Wu WH. Connexin 43 SUMOylation improves gap junction functions between liver cancer stem cells and enhances their sensitivity to HSVtk/GCV. International Journal of Oncology. 2018;52:872–880.
- Campbell HK, Maiers JL, DeMali KA. Interplay between tight junctions & adherens junctions. Experimental Cell Research. 2017;358(1):39–44. doi:https://doi.org/10.1016/j.yexcr.2017.03.061.
- Dianati E, Poiraud J, Weber-Ouellette A, Plante I. Connexins, E-cadherin, Claudin-7 and beta-catenin transiently form junctional nexuses during the post-natal mammary gland development. Dev Biol. 2016;416(1):52–68. doi:https://doi.org/10.1016/j.ydbio.2016.06.011.
- Angst BD, Khan LUR, Severs NJ, Whitely K, Rothery S, Thompson RP, Magee AI, Gourdie RG. Dissociated spatial patterning of gap junctions and cell adhesion junctions during postnatal differentiation of ventricular myocardium. Circ Res. 1997;80(1):88–94. doi:https://doi.org/10.1161/01.RES.80.1.88.
- Jongen WMF, Fitzgerald DJ, Asamoto M, Piccoli C, Slaga TJ, Gros D, Takeichi M, Yamasaki H. Regulation of Connexin 43-Mediated Gap Junctional Intercellular Communication by Ca2+ in Mouse Epidermal-Cells Is Controlled by E-Cadherin. Journal of Cell Biology. 1991;114(3):545–555. doi:https://doi.org/10.1083/jcb.114.3.545.
- Matsushita T, Oyamada M, Fujimoto K, Yasuda Y, Masuda S, Wada Y, Oka T, Takamatsu T. Remodeling of cell-cell and cell-extracellular matrix interactions at the border zone of rat myocardial infarcts. Circ Res. 1999;85(11):1046–1055. doi:https://doi.org/10.1161/01.RES.85.11.1046.
- Govindarajan R, Chakraborty S, Johnson KE, Falk MM, Wheelock MJ, Johnson KR, Mehta PP. Assembly of connexin43 into gap junctions is regulated differentially by E-cadherin and N-cadherin in rat liver epithelial cells. Mol Biol Cell. 2010;21:4089–4107.
- Wei CJ, Francis R, Xu X, Lo CW. Connexin43 associated with an N-cadherin-containing multiprotein complex is required for gap junction formation in NIH3T3 cells. Journal of Biological Chemistry. 2005;280(20):19925–19936. doi:https://doi.org/10.1074/jbc.M412921200.
- Nishimura M, Saito T, Yamasaki H, Kudo R. Suppression of gap junctional intercellular communication via 5 ‘ CpG island methylation in promoter region of E-cadherin gene in endometrial cancer cells. Carcinogenesis. 2003;24(10):1615–1623. doi:https://doi.org/10.1093/carcin/bgg121.
- Wincewicz A, Baltaziak M, Kanczuga-Koda L, Lesniewicz T, Rutkowski R, Sobaniec-Lotowska M, Sulkowski S, Koda M, Sulkowska M. Aberrant Distributions and Relationships Among E-cadherin, beta-catenin, and Connexin 26 and 43 in Endometrioid Adenocarcinomas. Int J Gynecol Pathol. 2010;29(4):358–365. doi:https://doi.org/10.1097/PGP.0b013e3181c3c57f.
- Chakraborty S, Mitra S, Falk MM, Caplan SH, Wheelock MJ, Johnson KR, Mehta PP. E-cadherin Differentially Regulates the Assembly of Connexin43 and Connexin32 into Gap Junctions in Human Squamous Carcinoma Cells. Journal of Biological Chemistry. 2010;285(14):10761–10776. doi:https://doi.org/10.1074/jbc.M109.053348.
- Yu SC, Xiao HL, Jiang XF, Wang QL, Li Y, Yang XJ, Ping YF, Duan JJ, Jiang JY, Ye XZ, et al. Connexin 43 Reverses Malignant Phenotypes of Glioma Stem Cells by Modulating E-Cadherin. Stem Cells. 2012;30(2):108–120. doi:https://doi.org/10.1002/stem.1685.
- Kotini M, Barriga EH, Leslie J, Gentzel M, Rauschenberger V, Schambony A, Mayor R. Gap junction protein Connexin-43 is a direct transcriptional regulator of N-cadherin in vivo. Nat Commun. 2018;9(1):3846. doi:https://doi.org/10.1038/s41467-018-06368-x.
- Oxford EM, Musa H, Maass K, Coombs W, Taffet SM, Delmar M. Connexin43 remodeling caused by inhibition of plakophilin-2 expression in cardiac cells. Circ Res. 2007;101(7):703–711. doi:https://doi.org/10.1161/CIRCRESAHA.107.154252.
- Gomes J, Finlay M, Ahmed AK, Ciaccio EJ, Asimaki A, Saffitz JE, Quarta G, Nobles M, Syrris P, Chaubey S, et al. Electrophysiological abnormalities precede overt structural changes in arrhythmogenic right ventricular cardiomyopathy due to mutations in desmoplakin-A combined murine and human study. Eur Heart J. 2012;33(15):1942–1953. doi:https://doi.org/10.1093/eurheartj/ehr472.
- Lyon RC, Mezzano V, Wright AT, Pfeiffer E, Chuang J, Banares K, Castaneda A, Ouyang KF, Cui L, Contu R, et al. Connexin defects underlie arrhythmogenic right ventricular cardiomyopathy in a novel mouse model. Hum Mol Genet. 2014;23(5):1134–1150. doi:https://doi.org/10.1093/hmg/ddt508.
- Kam CY, Dubash AD, Magistrati E, Polo S, Satchell KJF, Sheikh F, Lampe PD, Green KJ. Desmoplakin maintains gap junctions by inhibiting Ras/MAPK and lysosomal degradation of connexin-43. Journal of Cell Biology. 2018;217(9):3219–3235. doi:https://doi.org/10.1083/jcb.201710161.
- Rhett JM, Jourdan J, Gourdie RG. Connexin 43 connexon to gap junction transition is regulated by zonula occludens-1. Molecular Biology of the Cell. 2011;22(9):1516–1528. doi:https://doi.org/10.1091/mbc.e10-06-0548.
- Talhouk RS, Mroue R, Mokalled M, Abi-Mosleh L, Nehme R, Ismail A, Khalil A, Zaatari M, El-Sabban ME. Heterocellular interaction enhances recruitment of alpha and beta-catenins and ZO-2 into functional gap-junction complexes and induces gap junction-dependant differentiation of mammary epithelial cells. Experimental Cell Research. 2008;314(18):3275–3291. doi:https://doi.org/10.1016/j.yexcr.2008.07.030.
- Talhouk RS, Fares MB, Rahme GJ, Hariri HH, Rayess T, Dbouk HA, Bazzoun D, Al-Labban D, El-Sabban ME. Context dependent reversion of tumor phenotype by connexin-43 expression in MDA-MB231 cells and MCF-7 cells: role of beta-catenin/connexin43 association. Exp Cell Res. 2013;319(20):3065–3080. doi:https://doi.org/10.1016/j.yexcr.2013.10.002.
- Duffy HS, John GR, Lee SC, Brosnan CF, Spray DC. Reciprocal regulation of the junctional proteins claudin-1 and connexin43 by interleukin-1 beta in primary human fetal astrocytes. J Neurosci. 2000;20(23):23. doi:https://doi.org/10.1523/JNEUROSCI.20-23-j0004.2000.
- Kojima T, Kokai Y, Chiba H, Yamamoto M, Spray D, Mochizuki Y, Sawada N. Cx32 formation and/or Cx32 mediated intercellular communication induce tight junctions in hepatocytes. Molecular Biology of the Cell. 2000;11:330a–330a.
- Shaw RM, Fay AJ, Puthenveedu MA, von Zastrow M, Jan YN, Jan LY. Microtubule plus-end-tracking proteins target gap junctions directly from the cell interior to adherens junctions. Cell. 2007;128(3):547–560. doi:https://doi.org/10.1016/j.cell.2006.12.037.
- Giepmans BNG, Verlaan I, Moolenaar WH. Connexin-43 interactions with ZO-1 and alpha- and beta-tubulin. Cell Communication and Adhesion. 2001;8(4–6):219–223. doi:https://doi.org/10.3109/15419060109080727.
- Butkevich E, Hulsmann S, Wenzel D, Shirao T, Duden R, Majoul I. Drebrin is a novel connexin-43 binding partner that links gap junctions to the submembrane cytoskeleton. Curr Biol. 2004;14(8):650–658. doi:https://doi.org/10.1016/j.cub.2004.03.063.
- Crespin S, Bechberger J, Mesnil M, Naus CC, Sin WC. The Carboxy-Terminal Tail of Connexin43 Gap Junction Protein Is Sufficient to Mediate Cytoskeleton Changes in Human Glioma Cells. J Cell Biochem. 2010;110(3):589–597. doi:https://doi.org/10.1002/jcb.22554.
- Muscarella AM, Dai W, Mitchell PG, Zhang WJ, Wang H, Jia LY, Stossi F, Mancini MA, Chiu W, Zhang XHF. Unique cellular protrusions mediate breast cancer cell migration by tethering to osteogenic cells. Npj Breast Cancer. 2020;6(1):1. doi:https://doi.org/10.1038/s41523-020-00183-8.
- Herve JC. Gap junction channels: from protein genes to diseases. Prog Biophys Mol Bio. 2007;94(1–2):1–4. doi:https://doi.org/10.1016/j.pbiomolbio.2007.03.012.
- Petit C, Levilliers J, Hardelin JP. Molecular genetics of hearing loss. Annu Rev Genet. 2001;35(1):589–646. doi:https://doi.org/10.1146/annurev.genet.35.102401.091224.
- Mese G, Londin E, Mui R, Brink PR, White TW. Altered gating properties of functional Cx26 mutants associated with recessive non-syndromic hearing loss. Hum Genet. 2004;115(3):191–199. doi:https://doi.org/10.1007/s00439-004-1142-6.
- Mese G, Valiunas V, Brink PR, White TW. Connexin26 deafness associated mutations show altered permeability to large cationic molecules. Am J Physiol-Cell Ph. 2008;295(4):C966–C974. doi:https://doi.org/10.1152/ajpcell.00008.2008.
- Hall JE. A junction of transparency. Focus on “Functional effects of Cx50 mutations associated with congenital cataracts”. Am J Physiol-Cell Ph. 2014;306(3):C200–C201. doi:https://doi.org/10.1152/ajpcell.00323.2013.
- Pal JD, Liu XQ, Mackay D, Shiels A, Berthoud VM, Beyer EC, Ebihara L. Connexin46 mutations linked to congenital cataract show loss of gap junction channel function. Am J Physiol-Cell Ph. 2000;279(3):C596–C602. doi:https://doi.org/10.1152/ajpcell.2000.279.3.C596.
- Ionasescu V, Searby C, Ionasescu R. Point Mutations of the Connexin32 (Gjb1) Gene in X-Linked Dominant Charcot-Marie-Tooth Neuropathy. Hum Mol Genet. 1994;3(2):355–358. doi:https://doi.org/10.1093/hmg/3.2.355.
- Mese G, Sellitto C, Li LP, Wang HZ, Valiunas V, Richard G, Brink PR, White TW. The Cx26-G45E mutation displays increased hemichannel activity in a mouse model of the lethal form of keratitis-ichthyosis-deafness syndrome. Molecular Biology of the Cell. 2011;22(24):4776–4786. doi:https://doi.org/10.1091/mbc.e11-09-0778.
- Aypek H, Bay V, Mese G. Altered cellular localization and hemichannel activities of KID syndrome associated connexin26 I30N and D50Y mutations. Bmc Cell Biol. 2016;17:5. doi: https://doi.org/10.1186/s12860-016-0081-0.
- Hanahan D, Weinberg RA. The hallmarks of cancer. Cell. 2000;100(1):57–70. doi:https://doi.org/10.1016/S0092-8674(00)81683-9.
- Hanahan D, Weinberg RA. Hallmarks of Cancer: the Next Generation. Cell. 2011;144(5):646–674. doi:https://doi.org/10.1016/j.cell.2011.02.013.
- Mehta PP, Bertram JS, Loewenstein WR. Growth-Inhibition of Transformed-Cells Correlates with Their Junctional Communication with Normal-Cells. Cell. 1986;44(1):187–196. doi:https://doi.org/10.1016/0092-8674(86)90497-6.
- Loewenstein WR, Kanno Y. Intercellular communication and the control of tissue growth: lack of communication between cancer cells. Nature. 1966;209(5029):1248–1249. doi:https://doi.org/10.1038/2091248a0.
- Azarnia R, Loewenstein WR. Intercellular Communication and the Control of Growth .10. Alteration of Junctional Permeability by the Src Gene - a Study with Temperature-Sensitive Mutant Rous-Sarcoma Virus. J Membrane Biol. 1984;82(3):191–205. doi:https://doi.org/10.1007/BF01871629.
- Mesnil M, Crespin S, Avanzo JL, Zaidan-Dagli ML. Defective gap junctional intercellular communication in the carcinogenic process. Bba-Biomembranes. 2005;1719(1–2):125–145. doi:https://doi.org/10.1016/j.bbamem.2005.11.004.
- Cronier L, Crespin S, Strale PO, Defamie N, Mesnil M, Junctions G. Cancer: new Functions for an Old Story. Antioxid Redox Sign. 2009;11(2):323–338. doi:https://doi.org/10.1089/ars.2008.2153.
- Hellmann P, Grummer R, Schirrmacher K, Rook M, Traub O, Winterhager E. Transfection with different connexin genes alters growth and differentiation of human choriocarcinoma cells. Experimental Cell Research. 1999;246(2):480–490. doi:https://doi.org/10.1006/excr.1998.4332.
- Zhu D, Caveney S, Kidder GM, Naus CCG. Transfection of C6 Glioma-Cells with Connexin-43 Cdna - Analysis of Expression, Intercellular Coupling, and Cell-Proliferation. P Natl Acad Sci USA. 1991;88(5):1883–1887. doi:https://doi.org/10.1073/pnas.88.5.1883.
- Hirschi KK, Xu CE, Tsukamoto T, Sager R. Gap junction genes Cx26 and Cx43 individually suppress the cancer phenotype of human mammary carcinoma cells and restore differentiation potential. Cell Growth Differ. 1996;7:861–870.
- McLachlan E, Shao Q, Wang HL, Langlois S, Laird DW. Connexins act as tumor suppressors in three-dimensional mammary cell organoids by regulating differentiation and angiogenesis. Cancer Res. 2006;66(20):9886–9894. doi:https://doi.org/10.1158/0008-5472.CAN-05-4302.
- Plante I, Stewart MKG, Barr K, Allan AL, Laird DW. Cx43 suppresses mammary tumor metastasis to the lung in a Cx43 mutant mouse model of human disease. Oncogene. 2011;30(14):1681–1692. doi:https://doi.org/10.1038/onc.2010.551.
- Alaga KC, Crawford M, Dagnino L, Laird DW. Aberrant Cx43 Expression and Mislocalization in Metastatic Human Melanomas. J Cancer. 2017;8(7):1123–1128. doi:https://doi.org/10.7150/jca.18569.
- Tang B, Peng ZH, Yu PW, Yu G, Qian F. Expression and significance of Cx43 and E-cadherin in gastric cancer and metastatic lymph nodes. Medical Oncology. 2011;28(2):502–508. doi:https://doi.org/10.1007/s12032-010-9492-5.
- Zhao JQ, Sun FJ, Liu SS, Yang J, Wu YQ, Li GS, Chen QY, Wang JX. Expression of Connexin 43 and E-cadherin Protein and mRNA in Non-small Cell Lung Cancers in Chinese Patients. Asian Pac J Cancer P. 2013;14(2):639–643. doi:https://doi.org/10.7314/APJCP.2013.14.2.639.
- Ezumi K, Yamamoto H, Murata K, Higashiyama M, Damdinsuren B, Nakamura Y, Kyo N, Okami J, Ngan CY, Takemasa I, et al. Aberrant expression of connexin 26 is associated with lung metastasis of colorectal cancer. Clin Cancer Res. 2008;14(3):677–684. doi:https://doi.org/10.1158/1078-0432.CCR-07-1184.
- Krutovskikh V, Mazzoleni G, Mironov N, Omori Y, Aguelon AM, Mesnil M, Berger F, Partensky C, Yamasaki H, Homologous A. Heterologous Gap-Junctional Intercellular Communication in Primary Human Liver-Tumors Associated with Aberrant Protein Localization but Not Gene Mutation of Connexin-32. International Journal of Cancer. 1994;56(1):87–94. doi:https://doi.org/10.1002/ijc.2910560116.
- Eghbali B, Kessler JA, Reid LM, Roy C, Spray DC. Involvement of Gap-Junctions in Tumorigenesis - Transfection of Tumor-Cells with Connexin-32 Cdna Retards Growth-Invivo. P Natl Acad Sci USA. 1991;88(23):10701–10705. doi:https://doi.org/10.1073/pnas.88.23.10701.
- Momiyama M, Omori Y, Ishizaki Y, Nishikawa Y, Tokairin T, Ogawa J, Enomoto K. Connexin26-mediated gap junctional communication reverses the malignant phenotype of MCF-7 breast cancer cells. Cancer Sci. 2003;94(6):501–507. doi:https://doi.org/10.1111/j.1349-7006.2003.tb01473.x.
- Yang J, Liu B, Wang Q, Yuan DD, Hong XT, Yang Y, Tao L. Connexin 32 and its derived homotypic gap junctional intercellular communication inhibit the migration and invasion of transfected HeLa cells via enhancement of intercellular adhesion. Molecular Medicine Reports. 2011;4:971–979.
- Kameritsch P, Khandoga N, Pohl U, Pogoda K. Gap junctional communication promotes apoptosis in a connexin-type-dependent manner. Cell Death & Disease. 2013;4(4):e584. doi: https://doi.org/10.1038/cddis.2013.105.
- Krutovskikh VA, Piccoli C, Yamasaki H. Gap junction intercellular communication propagates cell death in cancerous cells (vol 21, pg 1989, 2002). Oncogene. 2002;21(28):4471. doi:https://doi.org/10.1038/sj.onc.1205567.
- Polusani SR, Kalmykov EA, Chandrasekhar A, Zucker SN, Nicholson BJ. Cell coupling mediated by connexin 26 selectively contributes to reduced adhesivity and increased migration. Journal of Cell Science. 2016;129:4399–4410.
- Hong XT, Sin WC, Harris AL, Naus CC. Gap junctions modulate glioma invasion by direct transfer of microRNA. Oncotarget. 2015;6(17):15566–15577. doi:https://doi.org/10.18632/oncotarget.3904.
- Strale PO, Clarhaut J, Lamiche C, Cronier L, Mesnil M, Defamie N. Down-Regulation of Connexin43 Expression Reveals the Involvement of Caveolin-1 Containing Lipid Rafts in Human U251 Glioblastoma Cell Invasion. Mol Carcinogen. 2012;51(11):845–860. doi:https://doi.org/10.1002/mc.20853.
- Chen Q, Boire A, Jin X, Valiente M, Er EE, Lopez-Soto A, Jacob LS, Patwa R, Shah H, Xu K, et al. Carcinoma-astrocyte gap junctions promote brain metastasis by cGAMP transfer. Nature. 2016;533(7604):493-+. doi:https://doi.org/10.1038/nature18268.
- Ito A, Katoh F, Kataoka TR, Okada M, Tsubota N, Asada H, Yoshikawa K, Maeda S, Kitamura Y, Yamasaki H, et al. A role for heterologous gap junctions between melanoma and endothelial cells in metastasis. Journal of Clinical Investigation. 2000;105(9):1189–1197. doi:https://doi.org/10.1172/JCI8257.
- Zhou JZ, Riquelme MA, Gu S, Kar R, Gao X, Sun L, Jiang JX. Osteocytic connexin hemichannels suppress breast cancer growth and bone metastasis. Oncogene. 2016;35(43):5597–5607. doi:https://doi.org/10.1038/onc.2016.101.
- Murphy SF, Varghese RT, Lamouille S, Guo SJ, Pridham KJ, Kanabur P, Osimani AM, Sharma S, Jourdan J, Rodgers CM, et al. Connexin 43 Inhibition Sensitizes Chemoresistant Glioblastoma Cells to Temozolomide. Cancer Research. 2016;76(1):139–149. doi:https://doi.org/10.1158/0008-5472.CAN-15-1286.
- Krutovskikh VA, Troyanovsky SM, Piccoli C, Tsuda H, Asamoto M, Yamasaki H. Differential effect of subcellular localization of communication impairing gap junction protein connexin43 on tumor cell growth in vivo. Oncogene. 2000;19(4):505–513. doi:https://doi.org/10.1038/sj.onc.1203340.
- Sun Y, Zhao XP, Yao YT, Qi XY, Yuan YZ, Hu Y. Connexin 43 interacts with Bax to regulate apoptosis of pancreatic cancer through a gap junction-independent pathway. International Journal of Oncology. 2012;41(3):941–948. doi:https://doi.org/10.3892/ijo.2012.1524.
- Talhouk RS, Fares MB, Rahme GJ, Hariri HH, Rayess T, Dbouk HA, Bazzoun D, Al-Labban D, El-Sabban ME. Context dependent reversion of tumor phenotype by connexin-43 expression in MDA-MB231 cells and MCF-7 cells: role of beta-catenin/connexin43 association. Experimental Cell Research. 2013;319:3065–3080.
- MacDonald AI, Sun P, Hernandez-Lopez H, Aasen T, Hodgins MB, Edward M, Roberts S, Massimi P, Thomas M, Banks L, et al. A functional interaction between the MAGUK protein hDlg and the gap junction protein connexin 43 in cervical tumour cells. Biochemical Journal. 2012;446(1):9–21. doi:https://doi.org/10.1042/BJ20111144.
- Xu HT, Li QC, Zhang YX, Zhao Y, Liu Y, Yang ZQ, Wang EH. Connexin 43 recruits E-cadherin expression and inhibits the malignant behaviour of lung cancer cells. Folia Histochem Cytobiol. 2008;46(3):315–321. doi:https://doi.org/10.2478/v10042-008-0057-9.
- Gellhaus A, Dong XS, Propson S, Maass K, Klein-Hitpass L, Kibschull M, Traub O, Willecke K, Perbal B, Lye SJ, et al. Connexin43 interacts with NOV - A possible mechanism for negative regulation of cell growth in choriocarcinoma cells. Journal of Biological Chemistry. 2004;279(35):36931–36942. doi:https://doi.org/10.1074/jbc.M404073200.
- Zhang YW, Morita I, Ikeda M, Ma KW, Murota S. Connexin43 suppresses proliferation of osteosarcoma U2OS cells through post-transcriptional regulation of p27. Oncogene. 2001;20(31):4138–4149. doi:https://doi.org/10.1038/sj.onc.1204563.
- Duffy HS, Iacobas I, Hotchkiss K, Hirst-Jensen BJ, Bosco A, Dandachi N, Dermietzel R, Sorgen PL, Spray DC. The gap junction protein connexin32 interacts with the Src homology 3/hook domain of discs large homolog 1. J Biol Chem. 2007;282(13):9789–9796. doi:https://doi.org/10.1074/jbc.M605261200.
- Yang Y, Zhang N, Zhu J, Hong XT, Liu H, Ou YR, Su F, Wang R, Li YM, Wu Q. Downregulated connexin32 promotes EMT through the Wnt/beta-catenin pathway by targeting Snail expression in hepatocellular carcinoma. Int J Oncol. 2017;50(6):1977–1988. doi:https://doi.org/10.3892/ijo.2017.3985.
- Kanczuga-Koda L, Sulkowski S, Tomaszewski J, Koda M, Sulkowska M, Przystupa W, Golaszewska J, Baltaziak M. Connexins 26 and 43 correlate with Bak, but not with Bcl-2 protein in breast cancer. Oncology Reports. 2005;14:325–329.
- Thiagarajan PS, Sinyuk M, Turaga SM, Mulkearns-Hubert EE, Hale JS, Rao V, Demelash A, Saygin C, China A, Alban TJ, et al. Cx26 drives self-renewal in triple-negative breast cancer via interaction with NANOG and focal adhesion kinase. Nat Commun. 2018;9(1):578. doi:https://doi.org/10.1038/s41467-018-02938-1.
- Martin F, Stein T, Howlin J. Springer Science+Business Media, Mammary gland development: methods and protocols. New York/USA: Humana Press; 2017. Vol. xi. p. 358.
- Pozzi A, Risek B, Kiang DT, Gilula NB, Kumar NM. Analysis of Multiple Gap Junction Gene-Products in the Rodent and Human Mammary-Gland. Experimental Cell Research. 1995;220:212–219.
- El-Saghir JA, El-Habre ET, El-Sabban ME, Talhouk RS. Connexins: a junctional crossroad to breast cancer. International Journal of Developmental Biology. 2011;55(7–9):773–780. doi:https://doi.org/10.1387/ijdb.113372je.
- Weber PA, Chang HC, Spaeth KE, Nitsche JM, Nicholson BJ. The permeability of gap junction channels to probes of different size is dependent on connexin composition and permeant-pore affinities. Biophys J. 2004;87(2):958–973. doi:https://doi.org/10.1529/biophysj.103.036350.
- Lambe T, Finlay D, Murphy M, Martin F. Differential expression of connexin 43 in mouse mammary cells. Cell Biol Int. 2006;30(5):472–479. doi:https://doi.org/10.1016/j.cellbi.2006.02.008.
- Teleki I, Szasz AM, Maros ME, Gyorffy B, Kulka J, Meggyeshazi N, Kiszner G, Balla P, Samu A, Krenacs T. Correlations of differentially expressed gap junction connexins Cx26, Cx30, Cx32, Cx43 and Cx46 with breast cancer progression and prognosis. PLoS One. 2014;9:e112541.
- Lee SW, Tomasetto C, Sager R. Positive Selection of Candidate Tumor-Suppressor Genes by Subtractive Hybridization. P Natl Acad Sci USA. 1991;88(7):2825–2829. doi:https://doi.org/10.1073/pnas.88.7.2825.
- Conklin C, Huntsman D, Yorida E, Makretsov N, Turbin D, Bechberger JF, Sin WC, Naus CC. Tissue microarray analysis of connexin expression and its prognostic significance in human breast cancer. Cancer Letters. 2007;255(2):284–294. doi:https://doi.org/10.1016/j.canlet.2007.05.001.
- Chasampalioti M, Green AR, Ellis IO, Rakha EA, Jackson AM, Spendlove I, Ramage JM. Connexin 43 is an independent predictor of patient outcome in breast cancer patients. Breast Cancer Res Tr. 2019;174(1):93–102. doi:https://doi.org/10.1007/s10549-018-5063-9.
- Lee SW, Tomasetto C, Paul D, Keyomarsi K, Sager R. Transcriptional downregulation of gap-junction proteins blocks junctional communication in human mammary tumor cell lines. The Journal of Cell Biology. 1992;118(5):1213–1221. doi:https://doi.org/10.1083/jcb.118.5.1213.
- Kanczuga-Koda L, Sulkowska M, Koda M, Rutkowski R, Sulkowski S. Increased expression of gap junction protein–connexin 32 in lymph node metastases of human ductal breast cancer. Folia Histochem Cyto. 2007;45:175–180.
- Nicolson GL, Dulski KM, Trosko JE. Loss of Intercellular Junctional Communication Correlates with Metastatic Potential in Mammary Adenocarcinoma Cells. P Natl Acad Sci USA. 1988;85(2):473–476. doi:https://doi.org/10.1073/pnas.85.2.473.
- Hamada J, Takeichi N, Kobayashi H. Inverse Correlation between the Metastatic Capacity of Cell Clones Derived from a Rat Mammary-Carcinoma and Their Intercellular Communication with Normal Fibroblasts. Jpn J Cancer Res. 1987;78:1175–1178.
- Stoletov K, Strnadel J, Zardouzian E, Momiyama M, Park FD, Kelber JA, Pizzo DP, Hoffman R, VandenBerg SR, Klemke RL. Role of connexins in metastatic breast cancer and melanoma brain colonization. Journal of Cell Science. 2013;126:904–913.
- Elzarrad MK, Haroon A, Willecke K, Dobrowolski R, Gillespie MN, Al-Mehdi AB. Connexin-43 upregulation in micrometastases and tumor vasculature and its role in tumor cell attachment to pulmonary endothelium. BMC Med. 2008;6:20. doi:https://doi.org/10.1186/1741-7015-6-20.
- Ming J, Zhou Y, Du JZ, Fan SH, Pan BB, Wang YH, Fan LJ, Jiang J. Identification of miR-200a as a novel suppressor of connexin 43 in breast cancer cells. Bioscience Rep. 2015;35(5):e00251. doi: https://doi.org/10.1042/BSR20150153.
- Anderson C, Catoe H, Werner R. MIR-206 regulates connexin43 expression during skeletal muscle development. Nucleic Acids Res. 2006;34(20):5863–5871. doi:https://doi.org/10.1093/nar/gkl743.
- Ming J, Zhou Y, Du JZ, Fan SG, Pan BB, Wang YH, Fan LJ, Jiang J. miR-381 suppresses C/EBP alpha-dependent Cx43 expression in breast cancer cells. Bioscience Rep. 2015;35(6):e00266. doi: https://doi.org/10.1042/BSR20150167.
- Brabletz T, Kalluri R, Nieto MA, Weinberg RA. EMT in cancer. Nature Reviews Cancer. 2018;18(2):128-+. doi:https://doi.org/10.1038/nrc.2017.118.
- Yang J, Qin G, Luo M, Chen J, Zhang Q, Li L, Pan L, Qin S. Reciprocal positive regulation between Cx26 and PI3K/Akt pathway confers acquired gefitinib resistance in NSCLC cells via GJIC-independent induction of EMT. Cell Death & Disease. 2015;6(7):e1829. doi: https://doi.org/10.1038/cddis.2015.197.
- Yu M, Han G, Qi B, Wu X. Cx32 reverses epithelial-mesenchymal transition in doxorubicin-resistant hepatocellular carcinoma. Oncol Rep. 2017;37(4):2121–2128. doi:https://doi.org/10.3892/or.2017.5462.
- Adak A, Unal YC, Yucel S, Vural Z, Turan FB, Yalcin-Ozuysal O, Ozcivici E, Mese G. Connexin 32 induces pro-tumorigenic features in MCF10A normal breast cells and MDA-MB-231 metastatic breast cancer cells. Bba-Mol Cell Res. 2020;1867:12.